Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
8.41
-0.06 (-0.71%)
At close: Feb 21, 2025, 4:00 PM
8.37
-0.04 (-0.47%)
After-hours: Feb 21, 2025, 4:43 PM EST
Avadel Pharmaceuticals Employees
Avadel Pharmaceuticals had 154 employees as of December 31, 2023. The number of employees increased by 113 or 275.61% compared to the previous year.
Employees
154
Change (1Y)
113
Growth (1Y)
275.61%
Revenue / Employee
$897,143
Profits / Employee
-$471,266
Market Cap
810.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
AVDL News
- 1 day ago - Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - Avadel Pharmaceuticals: Moving To A Speculative Buy - Seeking Alpha
- 12 days ago - ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors - Business Wire
- 5 weeks ago - 3 Oversold Biotech Names - Seeking Alpha
- 5 weeks ago - Avadel Pharmaceuticals: Patient Attrition Weighs On 2025 Outlook - Seeking Alpha
- 6 weeks ago - Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch - GlobeNewsWire
- 7 weeks ago - Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8 - GlobeNewsWire
- 3 months ago - Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference - GlobeNewsWire